"Workplace depression is now a global issue with devastating consequences for companies"
Join the global debate

at LSE

Dr. Sara Evans-Lacko leads world first study revealing US$246 billion cost of workplace depression

The consequence of depression on workplace productivity and global economics

"0.1-4.2% of a country’s GDP is lost due to workers with depression attending work whilst unwell"

Depression can have profound effects on cognitive function, with devastating effects on functional outcomes in the workplace.  These can manifest as a lack of concentration and reduced work productivity, affecting both the sufferer and their colleagues.1–3

Data from a survey of 8,000 employees across 8 countries showed that the economic effects of depression can be profound, with employees taking time off work due to their condition, or finding themselves reluctant to share their concerns with their employers.3

 

Dr. Sara Evans Lacko reveals the cost of workplace depression

Dr. Sara Evans Lacko reveals the cost of workplace depression

Dr. Sara Evans Lacko reveals the cost of workplace depression

LSE Workplace Depression Infographic

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References
  1. Conradi JH et al. Psychological Medicine. 2011;41:1165-1174
  2. Greer TL et al. CNS Drugs. 2010;24(4):267-284
  3. AbsenteeismEvans-Lacko, S. & Knapp, M. Soc Psychiatry Psychiatr Epidemiol (2016). doi:10.1007/s00127-016-1278-4
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country